Related Experiment Video
Updated: Sep 25, 2025

19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
18.7K
Dolutegravir Resistance in Malawi's National HIV Treatment Program
Joep J van Oosterhout1,2, Chifundo Chipungu1, Lyse Nkhoma3
1Partners in Hope, Lilongwe, Malawi.
Open Forum Infectious Diseases
|May 2, 2022
Abstract:
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on dolutegravir-based antiretroviral therapy (November 2020-September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 (30%) had dolutegravir HIVDR. Malawi urgently requires adequate HIVDR testing capacity.

